HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of Interleukin-6 Levels and Futile Reperfusion After Mechanical Thrombectomy.

AbstractOBJECTIVE:
To assess whether interleukin-6 (IL-6) level is a marker of futile reperfusion in patients with acute ischemic stroke (AIS) with large vessel occlusion treated with mechanical thrombectomy (MT).
METHODS:
The Cohort of Patients to Identify Biological and Imaging Markers of Cardiovascular Outcomes in Stroke (HIBISCUS-STROKE) includes patients with AIS treated with MT after MRI. We performed a sequential assessment of IL-6 (admission, 6 hours, 24 hours, 48 hours and 3 months from admission). Among patients with successful reperfusion (Thrombolysis in Cerebral Infarction scale 2b/3), reperfusion was considered effective if 3-month modified Rankin Scale (mRS) score was 0 to 2 and futile if 3-month mRS score was 3 to 6. Our model was adjusted for the main confounding variables.
RESULTS:
One hundred sixty-four patients represent the study population. One hundred thirty-three patients had successful reperfusion (81.1%), while in 46 (34.6%), reperfusion was classified as futile. In single-variable analyses, high IL-6 levels at 6, 24, and 48 hours in combination with a higher age, a prestroke mRS score >2, a history of hypertension or diabetes, lack of current smoking, a higher baseline NIH Stroke Scale score, the absence of associated intravenous thrombolysis, an intracranial internal carotid artery or a tandem occlusion, and an increased infarct growth were associated with futile reperfusion. After multivariable analyses, a high IL-6 level at 24 hours (odds ratio 6.15, 95% confidence interval 1.71-22.10) remained associated with futile reperfusion.
CONCLUSIONS:
IL-6 is a marker of futile reperfusion in the setting of MT.
AuthorsLaura Mechtouff, Thomas Bochaton, Alexandre Paccalet, Claire Crola Da Silva, Marielle Buisson, Camille Amaz, Laurent Derex, Elodie Ong, Yves Berthezene, Omer Faruk Eker, Nathalie Dufay, Nathan Mewton, Michel Ovize, Tae-Hee Cho, Norbert Nighoghossian
JournalNeurology (Neurology) Vol. 96 Issue 5 Pg. e752-e757 (02 02 2021) ISSN: 1526-632X [Electronic] United States
PMID33262232 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 American Academy of Neurology.
Chemical References
  • Interleukin-6
Topics
  • Aged
  • Aged, 80 and over
  • Endovascular Procedures
  • Female
  • Humans
  • Interleukin-6 (blood)
  • Ischemic Stroke (blood, surgery)
  • Male
  • Medical Futility
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Prognosis
  • Thrombectomy
  • Treatment Failure
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: